CD4 TEST, 200 cells/µl, wb, 1 test (Visitect AB376)
Valid Article
CD4 TEST, 200 cells/µl, wb, 1 test (Visitect AB376)
CAUTION
This test is worded and codified by unit to make the order easier, but it is always packaged in kit of 25.
Definition
The VISITECT CD4 lateral flow assay (LFA) is a disposable, that provides a visually read semi-quantitative result - above or below a threshold of 200 cells/µL - within 40 minutes.
This test is used for expanded screening of patients with advanced HIV disease (AHD).
Specifications
Components
- 25 foil pouch containing the test device and the desiccant
- 1x 7mL bottle buffer
- 25 Sample devices
- 25 Retractable sterile lancets
- 25 Alcohol swabs
- 1 Job aid for whole blood specimens
- 1 Job aid for whole blood specimens
- 1 Instructions for use
Technical specifications
- Specimen: 30 µL capillary or venous (EDTA); venous preferred
- Time to result: 40-45 minutes
- Format: Lateral flow cassette - visual reading
- Performance according to the WHO Prequalification report (July 2023):
- Venous whole blood:
- Sensitivity for detection of specimens with <=200 CD4+T cells/µL: 96,0% (95%CI: 90,1-98,9%)
- Specificity (>200CD4+T cells/µl) 96,6% (95%CI: 92,3-98,3)
- Capillary whole blood:
- Sensitivity for detection of specimens with <=200 CD4+T cells/µL: 95,0% (CI 95%: 88,7-98,4)
- Specifity (>200CD4+T cells/µl) : 97,0% (95% CI: 93,6-98,9)
- Performance review of published studies, see MSF internal communication, November 2025
Packaging & Labelling
25 tests/pack
Instructions for use
Read the manufacturer instruction for use.
The test result is interpreted by comparing the intensity of the Test (T) line with the Reference (200) line. If the test line has equal or weaker intensity than the reference line (200), the test result is 'below reference' (≤200 CD4+ T cells/μL). If the test (T) line has stronger intensity than the Reference (200) line, the test result is 'Above Reference' (> 200 CD4+ T cells/µl)
Precautions for Use
Important note about intended use:
- VISITECT CD4 Advanced Disease is for professional use only.
- VISITECT CD4 Advanced Disease is not intended for individuals <5 years of age.
- VISITECT CD4 Advanced Disease is not intended for use in the determination of HIV status.
- VISITECT CD4 Advanced Disease is not intended for self-testing.
Storage
- Store between 2-30°C. Do not freeze.
- Shelflife: 12 months
- Guaranteed minimum remaining shelf life at delivery: 1/3 of the total shelf life
MSF requirements
MSF recommends the expanded use of the VISITECT CD4 LFA for screening advanced HIV disease (AHD) in all settings where instrument-based CD4 testing is unavailable or limited.